Serum Soluble Programme Death-1 and Programme Death- Ligand 1 Identify Multiple Myeloma Patients: Serum sPDL-1 May Be a Prognostic Marker


Creative Commons License

TERZİ DEMİRSOY E., BİRTAŞ ATEŞOĞLU E., TARKUN P. , MEHTAP Ö. , GEDÜK A. , HACİHANİFİOĞLU A.

Eurasian Journal of Medical Investigation, 2019 (Other Refereed National Journals)

  • Publication Type: Article / Article
  • Publication Date: 2019
  • Doi Number: 10.14744/ejmi.2019.17854
  • Title of Journal : Eurasian Journal of Medical Investigation